The purpose of this study was to evaluate if changes in vascular properties were related to baroreflex function in patients with primary aldosteronism. Twenty-three patients with primary aldosteronism, 22 essential hypertensive patients and 16 normal controls were studied. Continuous finger blood pressure (BP) was recorded by Portapres device during supine rest and active stand up. Compliance was estimated from the time constant of pressure decay during diastole. Baroreflex sensitivity was calculated by autoregressive cross-spectral analysis of systolic BP and interbeat interval. The result was that baroreflex gain and compliance were lower in pri-
Introduction
During the development and progression of hypertension, the vascular structural changes may have substantial effects on baroreflex activity. In patients with essential hypertension, a reduced compliance of carotid artery is partially related to baroreflex disfunction. 1 Abnormal circulatory reflexes have also been reported in hypertensive patients with primary aldosteronism. 2 Recently, using the spectral analysis of blood pressure (BP) and heart rate variability, we found an impaired spontaneous baroreflex control of the heart rate in such patients. 3 Several studies have shown that a chronic mineralocorticoid excess leads to an increased collagen production inducing a perivascular fibrosis and heart remodelling in rats and humans. [4] [5] [6] Hence these vascular changes could reduce arterial compliance and impair the baroreflex sensitivity.
Spectral analysis of BP and heart rate variability has become a useful tool to assess the spontaneous baroreflex gain by means of cross-spectrum analysis and calculation of the alpha index. 7, 8 Furthermore, various methods have been proposed to calculate the parameters of the Windkessel model (including total arterial compliance) from analysis of the peripheral arterial pressure wave. 9, 10 In the conventional time-domain approach, compliance values are estimated from the time constant of arterial pressure decay during the diastolic portion of the arterial pressure wave.
The aim of the present study was to evaluate if the arterial compliance was reduced in patients with primary aldosteronism and if the impaired spontaneous baroreflex gain was related to a reduced arterial compliance, analysing finger arterial pressure waves recorded non-invasively by the Portapres device.
Materials and methods

Subjects
We studied 23 hypertensive patients with primary aldosteronism (PA: age 47.8 ± 2.3 years, 12M/11F), 22 BP-matched essential hypertensives (EH: age 47.5 ± 2.3 years, 13M/9F) and 16 normal controls (N: age 45.7 ± 2.3 years, 8M/8F). The diagnosis of primary aldosteronism was established by standard endocrine tests. 11 The differential diagnosis between aldosterone producing adenoma (APA) and idiopathic aldosteronism (IHA) was performed by a 6-(131-I)-iodo-methylnorcholesterol adrenal scan and adrenal computed tomography; when the TC scan was negative or inconclusive adrenal vein sampling was performed. Six patients had adrenal adenoma and 17 bilateral adrenal hyperplasia.
There was no evidence of renal injury or cardiac failure in any patient. The study was performed at our Clinical Division after informed consent had been obtained and patients were asked not to take any antihypertensive drugs or other medication and to follow a diet with a normal sodium content for almost 4 weeks before the test. Participants were asked to refrain from smoking, drinking coffee and taking sedatives for at least 24 h before test onset.
Ten PA patients (7M/3F: two APA/eight IHA) were also studied after 1 year after the treatment: two patients were treated with surgical therapy while eight subjects received pharmacological therapy (high dose of spironolactone). Two males discontinued spironolactone because of side effects (gynaecomastia, and reduction of libido); at the time of the study they were treated with Ca-antagonists and/or alpha-blockers.
Protocol
Study was performed in a quiet room between 9 am and 1 pm. After 30 min of supine rest, continuous finger BP was recorded by Portapres Model-2 device (TNO, Amsterdam, NL) at 200 Hz sampling frequency in the supine position for 15 min. The same procedure was repeated during 15 min of active stand up. Portapres provides an indirect measurement of BP in a finger based on the arterial volumeclamp method of Penaz and the physiocal (physiological calibration) criteria for the full unloading of the arteries in a manner identical to Finapres. 12, 13 The same finger was used both in the supine and upright position.
Data analysis
Data were then downloaded on a PC and analysed by the Beatfast program (TNO) to identify systolic (SBP) and diastolic (DBP) blood pressure values and interbeat intervals (IBI) for each cardiac cycle: after digital low pass filtering at 17 Hz, SBP is stored as the highest pressure level during the ejection. DBP is arterial end diastolic pressure just before the next upstroke begins. IBI is the time difference between two following systolic pressures.
Windkessel parameters
Compliance (C) was estimated from the time constant () of arterial pressure decay during diastole ( Figure 1 ): = R*C, where R are peripheral resistances. This method requires the computation of cardiac output (CO) and peripheral resistances (R): CO was estimated from the algorithm proposed and validated with invasive studies by Cohn et al 14 as a multivariate function of ejection time, heart rate, body surface area and age: stroke volume = −6.6 + (0.25 ET) − (0.62 HR) + (40.4 BSA) − 0.51 (Age), where ET is the ejection time in milliseconds, HR is heart rate in beats per minute and BSA is body surface area in squared meters. Peripheral resistances were then calculated as mean arterial pressure/CO.
For each period (supine and upright), a sequence of 150 to 250 arterial pressure waves were analysed. An automatic procedure implemented on MATLAB software provides the computation of compliance, CO and R for each wave, excluding artifacts and abnormal waveforms: a minimum of 100 valid waves was required for further evaluations. Mean values of Windkessel parameters were calculated for each period. 
Spectral analysis and baroreflex gain
For each period (supine and upright), a sequence of 400 to 600 data points (5-10 min) was analysed. The stationary point of BP and interbeat interval data was checked by visual inspection. Mean values of SBP, DBP, IBI were calculated. In the frequency domain, power spectral analysis of SBP, DBP and IBI was performed by the autoregressive method (Burg method) using custom software implemented on MATLAB program, after linear interpolation of data at 1 Hz frequency (to obtain equispaced data) and demeaning. The order of the autoregressive model was 13 ± 2.
The total power was then divided into low frequency (0.025 − 0.14 Hz, LF) and high frequency (0.14 − 0.4 Hz, HF) components. Spectral components of IBI variability were expressed in normalised units (by dividing the power of a given component by the total variance from which the direct current component had been subtracted, and multiplying by 100). The baroreflex gain was computed as alpha index, ie, the square root of the ratio of the powers of IBI in the LF range to corresponding SBP spectral components:
Hormonal measurements
At the end of the supine period and after 1 h of upright position, blood samples (7 ml) were withdrawn from the antecubital vein into K2-EDTA tubes placed on ice. Plasma was immediately separated and stored at −40°C until assayed. Plasma renin activity was assayed by radioimmunoassay (RIA) measuring the quantity of generated angiotensin I (Incstar Corp, Stillwater, MN, USA). Plasma aldosterone was measured by RIA (Sorin, Saluggia, Italy).
Plasma adrenaline and noradrenaline levels were assayed by high performance liquid chromatography with an electrochemical detector.
Statistical evaluation
Statistical evaluation was performed by the Statistical Analysis System (SAS Institute Inc, Cary, NC, USA) using ANOVA or t-test for paired data where appropriate. Pearson moment product correlation test was performed to analyse the strength of the relationship between two variables.
Further, multiple regression analysis with stepwise procedure was performed to evaluate the relative contribution of independent variables related to compliance. A value of P Ͻ 0.05 was taken as the level of statistical significance. Results are given as means ± s.e.m. Table 1 shows main clinical and biochemical parameters of patients studied. Body mass index was higher in PA and EH patients compared to N subjects. Aldosterone was lower in EH than PA patients, whereas plasma renin activity was higher in EH compared to PA patients.
Results
Haemodynamic parameters are shown in Table 2 . Systolic and diastolic BPs were significantly higher in PA and EH compared to N at rest (P Ͻ 0.0001) and during tilt. Also in orthostatic position PA showed DBP values higher than EH. Heart rate at rest did not differ between the three groups.
During standing, heart rate increased significantly in all groups (P Ͻ 0.05). Windkessel compliance were significantly lower in PA patients compared to N and EH at rest (P Ͻ 0.05) (Table 2, Figure 2 ).
Total peripheral resistances were higher in PA and EH patients at rest, compared to N controls (P = 0.004). In the upright position PA patients showed higher total peripheral resistances than the other two groups. This parameter increased significantly in PA and EH patients after tilt. CO did not differ between all groups at rest and during tilt, and it decreased significantly during tilt in PA and N subjects.
Spectral components of BP and HR variability are shown in Table 3 . Low frequency component of SBP and DBP variability at rest was significantly higher in PA and EH patients compared to N subjects. LFNU component of IBI variability in EH patients was significantly lower compared to N subjects after tilt. In both positions PA and EH patients showed a lower baroreflex gain compared to N subjects.
A direct correlation was found between baroreflex gain and compliance in the supine position (r = 0.31; P = 0.04, Figure 3 ) and during standing (r = 0.38, P = 0.01) when both EH and PA patients were considered.
An inverse relationship was found between LF component of SBP variability and compliance (r = − 0.49, P = 0.02) and baroreflex gain (r = −0.43, P = 0.03) in PA patients. Moreover, an inverse relationship was found between aldosterone plasma levels and compliance values in PA patients (r = −0.55, P = 0.01 at rest, r = −0.39, P = 0.08 after tilt, Figure 4 ). In the same group, aldosterone was also related to the LF component of SBP variability (r = 0.63, P = 0.005).
Multiple regression analysis with stepwise procedure was performed to identify independent variables related to compliance variability. The model included the variables shown in Table 4 .
Aldosterone plasma levels, age, systolic and diastolic BP, high and low frequency components of DBP variability were independently related to compliance in PA patients in the supine position.
After treatment PA patients showed significantly lower aldosterone levels and systolic and diastolic BP values in both positions (P Ͻ 0.01); also total peripheral resistances were reduced at rest and after tilt (Table 5) .
Discussion
Since 1966 Biglieri et al
2 found the absence of hypertensive overshoot after the Valsalva manoeuver and the abnormal responses to changes in posture in patients with primary aldosteronism, providing definite evidence of impairment of circulatory reflex activity in such patients.
Recently, we showed an impaired baroreflex sensitivity in patients with primary aldosteronism using power spectral analysis of BP and heart rate variability. 3 In the present study, we found that this alteration is in part related to a reduced compliance of the arterial tree. It is known that the arterial compliance reduction may be related to high BP levels in essential hypertension, [15] [16] [17] however, the stepwise multiple regression analysis of our data shows an independent and direct role of plasma aldosterone in reducing arterial compliance in patients with primary aldosteronism. Moreover, even if essential hypertensive patients present a decrease of arterial compliance compared to normal controls, this reduction does not reach the statistical significance, showing an additional role of the aldosterone increase in the reduction of arterial compliance. In addition, we confirm the evidence of increased total peripheral resistance and normal cardiac output in primary aldosteronism patients as previously reported.
18,19
Lage et al 1 found that in essential hypertensives, a reduced distensibility of the carotid artery blunts in part the baroreceptor response to increases in BP. In our study, we found that arterial compliance explains about 10% of baroreflex gain variability, suggesting the presence of multiple factors influencing baroreflex gain in primary aldosteronism patients. [20] [21] [22] In fact, several mechanisms could be proposed, including: (a) stimulation of cardiac volume receptors, 23 (b) modulation of peripheral sensory baroreceptive neurons (ie, by alteration in ions balance), or (c), a defect in central mechanisms involved in the coupling of the afferent baroreceptor activity to the efferent sympathetic drive. 24 However, in addition to the above mentioned functional mechanisms, structural changes of the arterial wall are likely to be involved, but to date there were no studies that evaluated this issue in primary aldosteronism patients.
Munakata et al 25 described increased baroreceptor sensitivity in primary aldosteronism patients compared to essential hypertensives, while no difference was found with respect to normotensives. These dis- cordant results could be due to several factors: first, all patients considered in that study were affected by aldosterone-producing adrenal adenoma; second, although the mean ages were similar in the two studies for all groups, their patients ranged from very young to elderly (12-74 years) and this could explain the different values of baroreflex sensitivity; third, their normal controls showed lower baroreflex gain compared to those obtained in most studies. [26] [27] [28] Since baroreflex sensitivity decreases with age, the presence of elderly subjects could explain these lower values. Analogous methodological differences between another study of the same author 29 and our own could explain the discordant results about BP variability in primary aldosteronism patients.
In normal subjects, Neutel et al 30 found that higher aldosterone plasma levels tended to be associated with reduced proximal arterial compliance. Moreover, a chronic mineralocorticoid excess leads to an increase in type I and III collagen mRNA, inducing a perivascular fibrosis and vascular remodelling in heart and vessels of human and animal models. [4] [5] [6] In vitro studies showed that aldosterone stimulates collagen synthesis in cultured adult rat cardiac fibroblasts, in concentrations similar to those found in renovascular hypertension: this response appears to occur via type I corticoid receptor. 31 As in essential hypertension, 1 the higher stiffness of the arterial walls can be responsible for the reduced discharge of the baroreceptors in primary aldosteronism patients.
Finally, ␣-adrenergic stimulation is associated with a reduction in arterial compliance 32 : in humans, mineralocorticoids increase pressor responsiveness to noradrenaline and angiotensin II. 33, 34 In this study we confirm higher LF components of systolic and diastolic BP variability, related to sympathetic vasomotor regulation, in patients with primary aldosteronism compared with normal subjects. The LF component of SBP was indirectly associated to compliance, to total peripheral resistances and to baroreflex gain, suggesting that the increased pressor responsiveness to sympathetic drive could also explain the higher stiffness of the arterial tree and the reduced baroreflex gain. The finding of normal plasma noradrenaline and adrenaline levels confirms that sympathetic outflow is not modified, as previously reported. 35, 36 In our study, we used the cross-spectral analysis of interbeat interval and BP variability to evaluate baroreflex sensitivity. This method offers several advantages on drug-induced baroreflex (eg, phenylephrine method), including the analysis of spontaneous fluctuations and the avoidance of drug administration that could itself affect baroreflex sensitivity. 37, 38 BP variability was evaluated by beat-to-beat noninvasive BP recorded by the Portapres device: this method has been shown to provide reliable BP values at rest and during laboratory manoeuvres. Moreover it can be used to assess BP variability by spectral analysis, with caution in the interpretation of low frequency components of SBP because of their magnification by non-invasive vs intra-arterial approach. 39 However in this study, the same approach was used in each group. thus, it is unlikely that the differences between groups were biased.
The assessment of arterial compliance of the Windkessel model was performed using the diastolic pressure decay model method on non-invasive BP recorded from a finger artery. Although the actual contour of the diastolic waveform may differ at different recording sites, these differences relate primarily to varying initial conditions that do not influence the time constant of BP decay. 10, 14 .
Moreover finger BP recording provides a good estimate of intra-arterial pressure in individual subjects 40 and we obtained haemodynamic data, (averaging at least 100 consecutive waves) superimposable to those obtained in previous studies. 18, 19 In conclusion the present study shows that the impaired baroreflex sensitivity of primary aldosteronism patients is also related to a reduced compliance of the arterial tree. Plasma aldosterone levels are associated to compliance changes. Two main mechanisms that may be involved include an increased collagen deposition in the vessel walls and/or an increased responsiveness to adrenergic stimulation.
Hence, our findings support the hypothesis that aldosterone may be responsible for structural changes of the arterial tree. Treatment of primary aldosteronism in our patients do not significantly modify compliance values, in spite of a reduction of BP, aldosterone and total peripheral resistances mean levels. Thus, we may suppose that structural modification of the arterial tree may take longer to resolve. It is also possible that the arterial changes may be irreversible. On the other hand, the lack of change in arterial compliance after treatment may reflect the use of medical therapy (spironolactone) in the majority of primary aldosteronism patients. Even if the mean aldosterone level is reduced after treatment, this is not true in each patient and it could be responsible for the lack of increase in arterial compliance.
Further studies are needed to evaluate if these alterations may play a remarkable role under a prognostic and therapeutic point of view in primary aldosteronism patients.
